Recombinant Human Insulin Injection can be used in the treatment of diabetes for the purpose of lowering blood sugar.
Recombinant Human Insulin Injection is mainly suitable for diabetic patients who use insulin to maintain their blood glucose levels, and can also be used in the treatment of gestational diabetes, which is correctly administered by subcutaneous injection, or by intravenous infusion.
This belongs to the hypoglycemic drugs, can play a role in lowering blood sugar, injection as well as intravenous drip use of the dose, should be adjusted by a professional physician according to the blood glucose level, the injection amount is too large, may cause hypoglycemic reactions, such as dizziness, fatigue, panic palpitations, etc., so to strictly comply with the doctor’s instructions for the use of medication.
The drug is contraindicated for hypoglycemia, allergy to human insulin and any of its excipients. It is recommended that during the treatment period, patients should not change the drug arbitrarily, and if there is any unstable blood glucose situation, give the medication adjustment in strict compliance with the doctor’s instructions to avoid adverse effects.